Back
Sinovac Biotech 10K Form
Sell
38
SVA
Sinovac Biotech
Last Price:
6.47
Seasonality Move:
4.45%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive SVA News And Ratings
See the #1 stock for the next 7 days that we like better than SVA
SVA Financial Statistics
Sales & Book Value
| Annual Sales: | $448.27M |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $120.36 |
| Price / Book: | 0.05 |
Profitability
| EPS (TTM): | -1.31000 |
|---|---|
| Net Income (TTM): | $-124.73M |
| Gross Margin: | $266.75M |
| Return on Equity: | -1.05% |
| Return on Assets: | -0.93% |
Sinovac Biotech Earnings Forecast
Key Sinovac Biotech Financial Ratios
- The Gross Profit Margin over the past 24 years for SVA is 59.51%.
- The Selling, General & Administrative Expenses for SVA have been equal to 104.03% of Gross Profit Margin.
- The Research & Development expenses have been 76.85% of Revenue.
- The Interest Expense is -2.26% of Operating Income.
- The Net Earning history of SVA is -22.29% of Total Revenues.
- Per Share Earnings over the last 25 years have been positive in 11 years.
Sinovac Biotech Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | SVA |
| CUSIP: | P8696W |
| Website: | sinovac.com |
Debt
| Debt-to-Equity Ratio: | 0.04 |
|---|---|
| Current Ratio: | 11.39 |
| Quick Ratio: | 11.22 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
SVA Technical Analysis vs Fundamental Analysis
Sell
38
Sinovac Biotech (SVA)
is a Sell
Is Sinovac Biotech a Buy or a Sell?
-
Sinovac Biotech stock is rated a Sell
The current Sinovac Biotech [SVA] share price is $6.47. The Score for SVA is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.